As shown in Table 3, TRPV1 rs8065080 was associated with an increased risk of migraine in the dominant model (CC + TC vs. TT: ORadj = 1.78, 95% CI = 1.09–2.90, p = 0.025). Here, TRPV1 is linked to migraine disorder.